Micafungin Versus Fluconazole in the Treatment of Invasive Candidiasis and Candidemia

Inclusion Criteria: * Patients with a confirmed diagnosis of candidemia and invasive candidiasis * Patients could be newly diagnosed with candidiasis who received no more than 48 hours of prior systemic antifungal therapy * Inpatients aged 16 and above Exclusion Criteria: * Patients with serious invasive candidiasis whose prognoses are considered to be poor (life expectancy judged to be less than 5 days). * Patients with severe complications in the liver * Pregnant or lactating women * Patients who have received at least 5 days of prior systemic treatment of fluconazole or echinocandin with no response. * Patients who have prior antifungal infection requiring treatment with systemic antifungal agents for conditions other than candidemia and invasive candidiasis.